
Keywords: Proton pump inhibitor (PPI); omeprazole; kidney transplantation; hip fracture; end-stage renal disease (ESRD); drug safety; peptic ulcer prophylaxis; renal transplant recipient; bone disease; modifiable risk factor; outcomes; case-control; US Renal Data S